Venture Capital

New research reveals food and beverage brands are misallocating ad spend by targeting a non-existent average consumer, ignoring three distinct buyer types.

With double-digit growth and key US acquisitions, ESTEVE is rapidly expanding. But it's the firm's B Corp status that may redefine success in pharma.

The Canadian miner's new OTCQB listing aims to attract American capital, fueling exploration of its promising gold and copper assets in British Columbia.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

The £87M take-private deal merges VertiGIS's applications with 1Spatial's data expertise, aiming to dominate the AI-driven geospatial solutions market.

With a $1.8M grant, AltaLink is using real-time weather data to unlock hidden capacity in power lines, saving money and boosting grid reliability.

NETGEAR smashed Q1 profit forecasts, driven by its booming enterprise unit. The company's strategic pivot to high-margin products is paying off.

With $5M in new funding and key regulatory validation, Sapho Bio's rapid sterility test promises to slash drug release times and speed medicines to patients.

With a $44M Series A, Guild.ai introduces a new platform to govern autonomous AI agents, aiming to solve the enterprise challenge of security and control.

With its new M1 multi-bay robotic system and $13M in fresh funding, Rocsys is automating the depot to unlock the future of autonomous vehicle fleets.

A new partnership between a sports tech startup and an NFL star's foundation reveals how AI is set to revolutionize training for everyday athletes.

The clinical trial leader renewed a key global certification, signaling a new era of quality and trust that could accelerate breakthroughs in Alzheimer's.

A new venture aims to replace your phone with AR glasses powered by 6G, but can it overcome huge tech hurdles and beat giants like Apple and Meta?

Mayors from eight nations gathered in Xi'an, forging a new consensus on tech, culture, and green growth at the historic Silk Road's starting point.

As AI accelerates drug approvals, a new bottleneck emerges. Firms like Totaligent are betting on the infrastructure needed to get therapies to patients.

Actor Terry Crews and 'Drive to Survive' creators team up for a new series taking fans inside the launch of the Cadillac Formula 1® team.

Marking its 10th year, The Odlum Brown Forum Pitch awarded three innovative women-led startups and raised a record $1.52 million to tackle the funding gap.

A new five-year partnership seeks to bridge the gap between clinical insight and investment, speeding up patient access to new medical technologies.

TRexBio has dosed the first patient in a new trial for its novel drug, TRB-061, which aims to rebalance the immune system to treat atopic dermatitis.

With its new Observability 3.0 platform, OpenObserve introduces an autonomous AI SRE agent to unify monitoring and slash costs, ending 'data diets'.